Showing results (161-170 of 4,701) with videos related to

Sort By:
Pageof 471
Therapeutic Drug Monitoring|November 20, 2019
Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life InvestigationDario Cattaneo, Sara Baldelli, Valeria Cozzi, et al.
Therapeutic Drug Monitoring|December 5, 2020
Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant RecipientsNasrullah Undre, Ian Dawson, Varuna Aluvihare, et al.
Therapeutic Drug Monitoring|December 5, 2020
Do Vancomycin Pharmacokinetics Differ Between Obese and Non-obese Patients? Comparison of a General-Purpose and Four Obesity-Specific Pharmacokinetic ModelsPieter J Colin, Douglas J Eleveld, Andrew Hart, et al.
Therapeutic Drug Monitoring|December 5, 2020
Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's PerspectiveShannon Gadd, Nicholas Cox, James Samuelson, et al.
Therapeutic Drug Monitoring|December 18, 2013
Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosisLi-Ling Yeap, Kheng-Seang Lim, Ching-Ching Ng, et al.
Therapeutic Drug Monitoring|December 18, 2013
Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophreniaDe-Wei Shang, Li-Jun Li, Xi-Pei Wang, et al.
Therapeutic Drug Monitoring|December 18, 2013
Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginaseClaudia Lanvers-Kaminsky, Petra Schulze Westhoff, Maurizio DʼIncalci, et al.
Therapeutic Drug Monitoring|December 19, 2013
Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsyJunji Saruwatari, Naoki Ogusu, Masatsugu Shimomasuda, et al.
Therapeutic Drug Monitoring|November 23, 2013
Development and evaluation of a nanoparticle-based immunoassay for determining paclitaxel concentrations on routine clinical analyzersDaniel J Cline, Hongxia Zhang, Gregory D Lundell, et al.
Therapeutic Drug Monitoring|January 5, 2022
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry AnalyzersNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Pageof 471